Marissa S. Fallon

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

Rajesh Krishna, Matt S. Anderson, Arthur Bergman et al. · The Lancet · 2007 · 276 citations

Metabolic Syndrome, Hypertension, Healthy Individuals +10

Pharmacokinetics and Safety of Caspofungin in Neonates and Infants Less than 3 Months of Age

Xavier Sáez‐Llorens, M. Macías, P. P. Maiya et al. · Antimicrobial Agents and Chemotherapy · 2008 · 138 citations · Full text

Neonatology, Candida Infections, Infant Nutrition +14

Multiple-Dose Pharmacodynamics and Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects

Rajesh Krishna, AJ Bergman, Bo Jin et al. · Clinical Pharmacology & Therapeutics · 2008 · 99 citations

High-density Lipoprotein, Healthy Subjects, Biochemistry +15

Sequestration of amitriptyline by liposomes

Marissa S. Fallon, Anuj Chauhan · Journal of Colloid and Interface Science · 2006 · 30 citations

Pharmacology, Lipid Preparation, Lipid Chemistry

A Physiologically-Based Pharmacokinetic Model of Drug Detoxification by Nanoparticles

Marissa S. Fallon, Manoj Varshney, Donn M. Dennis et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2004 · 17 citations · Full text

Nanomedicine, Drug Detoxification, Pharmacokinetic Modeling +3